As measured by phosphorylation of peptide substrate, each tumor cell line exhibited statistically different median levels of PKB activity (65%, 21%, and 4% phosphorylation in PANC-1 (human pancreatic ...

In parallel, we confirmed pyrimidine nucleotide depletion upon treatment with BQ at different doses by performing metabolomics analysis of CFPAC-1 and B16F10 cells following BQ treatment. The results ...

Idebenone significantly reduced cell proliferation and induced apoptosis in PC-3, CFPAC-1, HT-29, T-84 and Calu-3 cells having CaCCs activities. These data suggest that idebenone, an ANO1/CaCC ...

cell lines CFPAC-1, MIAPaCa-2 and PANC-1 using immunohistochemistry and multiplexed gene expression analysis. The direct anti-tumor effects of Ampligen were investigated using proliferation and ...

For the study, three PDAC cell lines (CFPAC-1, MIAPaCa-2, and PANC-1) were treated with various concentrations of Ampligen and their corresponding vehicle control. The proliferation and migration ...

PARP inhibitor olaparib and ETC‐159 synergistically prevent colony formation of EGI‐1, MCAS and CFPAC‐1 cells in soft agar. (F) Representative image of soft agar colonies of EGI‐1 cells is shown.

PARP inhibitor olaparib and ETC‐159 synergistically prevent colony formation of EGI‐1, MCAS and CFPAC‐1 cells in soft agar. (F) Representative image of soft agar colonies of EGI‐1 cells is shown.

CFPAC-1 + MSC-hsa-miR-143-3p inhibitor negative control (inhibitor NC) group, and CFPAC-1 + MSC- hsa-miR-143-3p inhibitor (Inhibitor) group. There were four concentrations for exosomes: 50, 100, 200, ...